Skip to main content

Table 2 Baseline characteristics of participants at each survey

From: Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali

 

2014 (Year 1)

2015 (Year 2)

2016 (Year 3)

Beginninga

(n = 571)

End

(n = 581)

Beginning

(n = 429)

End

(n = 487)

Beginning

(n = 747)

End

(n = 952)

Age (months)

 Mean (SD)

31.7 (16.4)

33.3 (16.6)

31.0 (15.9)

35.2 (15.2)

32.6 (15.7)

47.5 (8.1)

 Median (min–max)

32 (3–59)

32 (4–64)

31 (3–59)

35 (6–62)

33 (3–59)

47 (34–61)

Gender

 Male (%)

49.9

48.3

52.6

53.4

49.0

53.4

P. falciparum prevalence

51.9

23.1

37.3

26.1

26.6

49.3

  1. n, number of subjects
  2. aBaseline (no SMC)